Publications in collaboration with researchers from Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (29)

2023

  1. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study

    Vaccine, Vol. 41, Núm. 1, pp. 251-262

2022

  1. Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. e865-e868

2021

  1. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

2019

  1. Feasibility of point-of-care testing for influenza within a national primary care sentinel surveillance network in England: Protocol for a mixed methods study

    JMIR Research Protocols, Vol. 8, Núm. 11

  2. Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

    Human Vaccines and Immunotherapeutics, Vol. 15, Núm. 12, pp. 2865-2872

2018

  1. Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial

    Vaccine, Vol. 36, Núm. 38, pp. 5781-5788

2017

  1. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza

    Vaccine, Vol. 35, Núm. 34, pp. 4298-4306

2014

  1. It is time to abandon "expected bladder capacity." Systematic review and new models for children's normal maximum voided volumes

    Neurourology and Urodynamics, Vol. 33, Núm. 7, pp. 1092-1098

  2. Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)

    BMC Infectious Diseases, Vol. 14, Núm. 1

  3. Safety and immunogenicity of a vero cell culture-derived whole-virus influenza a(H5N1) vaccine in a pediatric population

    Journal of Infectious Diseases, Vol. 209, Núm. 1, pp. 12-23

2013

  1. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain

    Vaccine, Vol. 31, Núm. 46, pp. 5486-5494

  2. Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule

    Vaccine, Vol. 31, Núm. 42, pp. 4765-4774

  3. MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system

    Vaccine, Vol. 31, Núm. 37, pp. 3995-4002

  4. Mortality due to haematological cancer in cities close to petroleum refineries in Spain

    Environmental Science and Pollution Research, Vol. 20, Núm. 1, pp. 591-596

2012

  1. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case-case comparison, case-control study

    Vaccine, Vol. 30, Núm. 39, pp. 5714-5720

  2. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial

    JAMA, Vol. 307, Núm. 6, pp. 573-582

  3. Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 11, pp. 1166-1172

2011

  1. Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain

    HUMAN VACCINES

  2. Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)

    Vaccine, Vol. 29, Núm. 52, pp. 9640-9648

  3. Using random networks to study the dynamics of respiratory syncytial virus (RSV) in the Spanish region of Valencia

    Mathematical and Computer Modelling, Vol. 54, Núm. 7-8, pp. 1650-1654